Verastem, Inc.

Verastem, Inc.verified

2VSA.F

Price:

$8.95

Market Cap:

$627.18M

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of avutometinib and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202...[Read more]

Industry

Biotechnology

IPO Date

2012-02-13

Stock Exchange

FSX

Ticker

2VSA.F

The Enterprise Value as of December 2025 (TTM) for Verastem, Inc. (2VSA.F) is 547.57M

According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 547.57M. This represents a change of 293.82% compared to the average of 139.04M of the last 4 quarters.

Verastem, Inc. (2VSA.F) Historical Enterprise Value (quarterly & annually)

How has 2VSA.F Enterprise Value performed in the past?

The mean historical Enterprise Value of Verastem, Inc. over the last ten years is 133.44M. The current 547.57M Enterprise Value has changed 40.93% with respect to the historical average. Over the past ten years (40 quarters), 2VSA.F's Enterprise Value was at its highest in in the June 2021 quarter at 698.56M. The Enterprise Value was at its lowest in in the June 2023 quarter at -8664920.00.

Quarterly (TTM)
Annual

Average

133.44M

Median

140.16M

Minimum

-43424487.44

Maximum

339.46M

Verastem, Inc. (2VSA.F) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Verastem, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 457.50%

Maximum Annual Enterprise Value = 339.46M

Minimum Annual Increase = -121.50%

Minimum Annual Enterprise Value = -43424487.44

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024138.07M-2.93%
2023142.24M380.65%
202229.59M-91.28%
2021339.46M20.65%
2020281.35M71.61%
2019163.95M-26.64%
2018223.50M341.64%
201750.61M457.50%
20169.08M-120.90%
2015-43424487.44-121.50%

Verastem, Inc. (2VSA.F) Average Enterprise Value

How has 2VSA.F Enterprise Value performed in the past?

The current Enterprise Value of Verastem, Inc. (2VSA.F) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

103.30M

5-year avg

186.14M

10-year avg

133.44M

Verastem, Inc. (2VSA.F) Enterprise Value vs. Peers

How is 2VSA.F’s Enterprise Value compared to its peers?

Verastem, Inc.’s Enterprise Value is greater than Formycon AG (423.65M), greater than Zura Bio Limited (104.17M), greater than Heidelberg Pharma AG (99.27M), greater than 4basebio PLC (99.65M), greater than Medios AG (486.16M), greater than Stratec SE (388.38M), greater than BRAIN Biotech AG (55.67M), greater than Newron Pharmaceuticals S.p.A. (415.97M), greater than M1 Kliniken AG (315.10M), less than CureVac N.V. (633.43M),

CompanyEnterprise ValueMarket cap
423.65M$440.73M
104.17M$214.57M
99.27M$132.40M
99.65M$123.10M
486.16M$369.32M
388.38M$278.37M
55.67M$66.20M
415.97M$387.64M
315.10M$338.76M
633.43M$986.71M

Build a custom stock screener for Verastem, Inc. (2VSA.F) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verastem, Inc. (2VSA.F) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Verastem, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Verastem, Inc. (2VSA.F)?

What is the 3-year average Enterprise Value for Verastem, Inc. (2VSA.F)?

What is the 5-year average Enterprise Value for Verastem, Inc. (2VSA.F)?

How does the current Enterprise Value for Verastem, Inc. (2VSA.F) compare to its historical average?